Advertisement
Screener

PRINCIPIA BIOPHARMA INC. Patents: Active

PRINCIPIA BIOPHARMA INC. Active Patents

51 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-03-22: Application 18613641; Invention Therapeutic Tyrosine Kinase Inhibitors for Relapsing Multiple Sclerosis (RMS); Applicant Principia Biopharma Inc.; Status Patented Case.
  • 2023-12-01: Application 18526225; Invention Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile; Applicant Principia Biopharma Inc.; Status Patented Case.
  • 2023-10-17: Application 18380962; Invention Immunoproteasome Inhibitors; Applicant Principia Biopharma Inc.; Status Patented Case.
  • 2023-10-06: Application 18482278; Invention Crystalline Forms of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1- YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2- Enenitrile; Applicant Principia Biopharma Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2024-03-2218613641Therapeutic Tyrosine Kinase Inhibitors for Relapsing Multiple Sclerosis (RMS)Principia Biopharma Inc.Patented Case2026-05-2612636280US20240366585A1
Meehyung Cho
Timothy J. Turner
Erik Wallstroem
United States
United States
United States
YOO, SUN JAE
2023-12-0118526225Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-EnenitrilePrincipia Biopharma Inc.Patented Case2025-06-2412336999US20240207275A1
Abu J. Ferdous
Mohammad R. Masjedizadeh
Wu Lin
United States
United States
United Kingdom
VU, JAKE MINH
2023-10-1718380962Immunoproteasome InhibitorsPrincipia Biopharma Inc.Patented Case2025-05-2712312370US20240199655A1
Yan Lou
Timothy Duncan Owens
Kenneth Albert Brameld
David Michael Goldstein
United States
United States
United States
United States
SHAMEEM, GOLAM M
2023-10-0618482278Crystalline Forms of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1- YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2- EnenitrilePrincipia Biopharma Inc.Patented Case2025-09-0912410176US20240182484A1
Pasit Phiasivongsa
Kolbot By
Jean Baum
United States
United States
United States
SOLOLA, TAOFIQ A
2023-06-3018217002Quinolone Derivatives as Fibroblast Growth Factor Receptor InhibitorsPrincipia Biopharma Inc.Patented Case2024-12-1012162882US20240092777A1
Erik Verner
Kenneth Albert Brameld
United States
United States
SZNAIDMAN, MARCOS L
2023-06-20182685774-AMINO-3-(4-PHENOXYPHENYL)-1,3-DIHYDRO-2H-IMIDAZO[4,5-C]PYRIDIN-2-ONE DERIVATIVES AND SALTS THEREOFPrincipia Biopharma Inc.Patented Case2026-05-1212624030US20240051955A1
Catherine Arabeyre
Patricia Moliner
Sabine Boisnard
Damien Sallaberry
Serge Perard
Sebastien Roy
France
France
France
France
France
France
RAHMANI, NILOOFAR
2023-05-1618197979PROCESS FOR PREPARING AN AMORPHOUS FORM OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXYPHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILEPrincipia Biopharma Inc.Patented Case2026-07-0712673953US20230399330A1
Kolbot By
Katherine Chu
Mohammad R. Masjedizadeh
Pasit Phiasivongsa
Jiang Zhu
United States
United States
United States
United States
United States
WILLIS, DOUGLAS M
2023-04-2518306649CRYSTALLINE FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4,4-DIMETHYLPENT-2-ENENITRILEPrincipia Biopharma Inc.Patented Case2025-04-2212281120US20240190882A1
Kolbot By
Mohammad R. Masjedizadeh
Pasit Phiasivongsa
Jiang Zhu
United States
United States
United States
United States
WILLIS, DOUGLAS M
2022-09-1617946585Methods for Treating Immune Thrombocytopenia by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy- Phenyl) Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-EnenitrilePrincipia Biopharma Inc.Patented Case2024-12-3112178818US20230124267A1
Steven Gourlay
Ann Neale
Philip Nunn
Claire Langrish
Olga Bandman
Dolca Thomas
Australia
United States
United States
United States
United States
United States
PIHONAK, SARAH
2021-11-1617527514Immunoproteasome InhibitorsPrincipia Biopharma Inc.Patented Case2023-11-2811827656US20220073538A1
Yan Lou
Timothy Duncan Owens
Kenneth Albert Brameld
David Michael Goldstein
United States
United States
United States
United States
SHAMEEM, GOLAM M
2021-01-2217155726PROCESSES FOR PREPARING AN FGFR INHIBITORPrincipia Biopharma, Inc.Patented Case2025-04-2212281110US20210147417A1
Jiang ZHU
Mohammad MASJEDIZADEH
United States
United States
KENYON, JOHN S
2021-01-2117154452CRYSTALLINE FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILEPrincipia Biopharma Inc.Patented Case2023-11-1411814390US20210221818A1
Pasit Phiasivongsa
Kolbot By
Jean Baum
United States
United States
United States
SOLOLA, TAOFIQ A
2021-01-0717143384TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4,4-DIMETHYLPENT-2-ENENITRILEPrincipia Biopharma Inc.Patented Case2023-02-2111583533US20210205313A1
Katherine CHU
Jyoti WADHWA
Jason CARBOL
Pasit PHIASIVONGSA
Claire LANGRISH
Dolca THOMAS
United States
United States
United States
United States
United States
United States
MERCIER, MELISSA S
2021-01-0717143355CRYSTALLINE FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXYPHENYL)-1H-PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4,4-DIMETHYLPENT-2-ENENITRILEPrincipia Biopharma Inc.Patented Case2023-06-0611667641US20210206772A1
Pasit Phiasivongsa
Jiang Zhu
Kolbot By
Mohammad Reza Masjedizadeh
United States
United States
United States
United States
WILLIS, DOUGLAS M
2020-12-1717125384SOLID FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXYPHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILEPrincipia Biopharma Inc.Patented Case2023-07-2511708370US20210198264A1
Pasit Phiasivongsa
Katherine Chu
Jiang Zhu
Kolbot By
Mohammad Reza Masjedizadeh
United States
United States
United States
United States
United States
WILLIS, DOUGLAS M
2020-10-2817082747MODIFIED RELEASE FORMULATIONS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILEPrincipia Biopharma Inc.Patented Case2024-01-1611872229US20210113567A1
Abu J. FERDOUS
Mohammad R. MASJEDIZADEH
Wu LIN
United States
United States
United Kingdom
VU, JAKE MINH
2020-10-0517063061SALTS AND SOLID FORM OF A BTK INHIBITORPRINCIPIA BIOPHARMA INC.Patented Case2022-06-2811369613US20210015821A1
Mohammad Reza MASJEDIZADEH
Steven Gourlay
United States
Australia
MURRAY, JEFFREY H
2020-05-1416764199IMMUNOPROTEASOME INHIBITORSPrincipia Biopharma Inc.Patented Case2024-07-0212024531US20230133165A1
Yan Lou
Timothy Duncan Owens
Kenneth Albert Brameld
David Michael Goldstein
United States
United States
United States
United States
O DELL, DAVID K
2020-05-1416764136IMMUNOPROTEASOME INHIBITORSPrincipia Biopharma Inc.Patented Case2022-01-1811225493US20200277312A1
Yan Lou
Timothy Duncan Owens
Kenneth Albert Brameld
David Michael Goldstein
United States
United States
United States
United States
SHAMEEM, GOLAM M
2020-01-1716745418PROCESSES FOR PREPARING AN FGFR INHIBITORPrincipia Biopharma, Inc.Patented Case2021-01-2610899760US20200148680A1
Jiang ZHU
Mohammad MASJEDIZADEH
United States
United States
BERNHARDT, EMILY A
2019-12-0916708340SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS KINASE INHIBITORSPRINCIPIA BIOPHARMA INC.Patented Case2021-06-2211040980US20200190092A1
Tim OWENS
Erik VERNER
United States
United States
WILLIS, DOUGLAS M
2019-10-0816596611SALTS AND SOLID FORM OF A BTK INHIBITORPRINCIPIA BIOPHARMA INC.Patented Case2020-11-1010828307US20200038405A1
Mohammad Reza MASJEDIZADEH
Steven GOURLAY
United States
United States
MURRAY, JEFFREY H
2019-10-0416593352TREATMENT OF PEMPHIGUSPrincipia Biopharma Inc.Patented Case2021-03-1610946008US20200101059A1
Steven GOURLAY
United States
CHANDRAKUMAR, NIZAL S
2019-07-2616523979HETEROCYCLE COMPRISING TYROSINE KINASE INHIBITORSPrincipia Biopharma Inc.Patented Case2021-10-2611155544US20190345159A1
David M. GOLDSTEIN
Timothy D. OWENS
United States
United States
RODRIGUEZ-GARCIA, VALERIE
2019-07-1716478788IMMUNOPROTEASOME INHIBITORSPrincipia Biopharma Inc.Patented Case2021-10-2611154563US20190336515A1
Yan Lou
Timothy Duncan Owens
Kenneth Albert Brameld
David Michael Goldstein
United States
United States
United States
United States
HABTE, KAHSAY
2019-04-1216383237QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORSPrincipia Biopharma, Inc.Patented Case2021-08-0311078199US20190233418A1
Erik VERNER
Kenneth Albert BRAMELD
United States
United States
SZNAIDMAN, MARCOS L
2018-08-2916116425SALTS AND SOLID FORM OF A BTK INHIBITORPRINCIPIA BIOPHARMA INC.Patented Case2019-10-2910456403US20190076435A1
Mohammad Reza MASJEDIZADEH
Steven GOURLAY
United States
United States
MURRAY, JEFFREY H
2018-05-1115978041SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS KINASE INHIBITORSPRINCIPIA BIOPHARMA INC.Patented Case2020-01-1410533013US20180327413A1
Tim OWENS
Erik VERNER
United States
United States
WILLIS, DOUGLAS M
2018-01-2915748212PROCESSES FOR PREPARING AN FGFR INHIBITORPrincipia Biopharma, Inc.Patented Case2020-01-2110538518US20180215756A1
Jiang ZHU
Mohammad MASJEDIZADEH
United States
United States
BERNHARDT, EMILY A
2017-11-2015575448QUINOLONE DERIVATIVES AS FGFR INHIBITORSPrincipia Biopharma, Inc.Patented Case2020-01-2110538517US20180155340A1
Kenneth Albert BRAMELD
Erik VERNER
United States
United States
NORTHINGTON DAVIS, ZINNA
2017-11-0815806525QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORSPrincipia Biopharma, Inc.Patented Case2019-05-2110294223US20180065960A1
Erik VERNER
Kenneth Albert BRAMELD
United States
United States
SZNAIDMAN, MARCOS L
2017-06-1615537294TREATMENT OF PEMPHIGUSPrincipia Biopharma Inc.Patented Case2019-11-2610485797US20180050027A1
Steven GOURLAY
United States
CHANDRAKUMAR, NIZAL S
2017-01-1915410716TYROSINE KINASE INHIBITORSPRINCIPIA BIOPHARMA INC.Patented Case2017-06-279688676US20170129890A1
Timothy D. OWENS
United States
DANIEL, LAURA M
2016-12-1915320155LMP7 INHIBITORSPRINCIPIA BIOPHARMA INC.Patented Case2020-05-1910654843US20180208589A1
Timothy Owens
Kenneth Albert Brameld
United States
United States
KENYON, JOHN S
2016-08-2515121605BENZIMIDAZOLE DERIVATIVES AS RLK AND ITK INHIBITORSPRINCIPIA BIOPHARMA, INC.Patented Case2018-04-039932329US20160368908A1
Timothy OWENS
Ronald J. HILL
United States
United States
AGUIRRE, AMANDA L
2016-08-1915120293SALTS AND SOLID FORM OF A BTK INHIBITORPRINCIPIA BIOPHARMA INC.Patented Case2018-10-0910092569US20170065591A1
Mohammad Reza MASJEDIZADEH
Steven GOURLAY
United States
United States
MURRAY, JEFFREY H
2016-03-2215077442QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORSPrincipia Biopharma, Inc.Patented Case2017-02-149567334US20160200725A1
Erik VERNER
Kenneth Albert BRAMELD
United States
United States
SZNAIDMAN, MARCOS L
2016-03-1715022869QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORSPRINCIPIA BIOPHARMA, INC.Patented Case2017-11-149815834US20160229849A1
Erik VERNER
Kenneth Albert BRAMELD
United States
United States
SZNAIDMAN, MARCOS L
2016-01-1514997330SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS KINASE INHIBITORSPRINCIPIA BIOPHARMA INC.Patented Case2018-06-129994576US20160251358A1
Tim OWENS
Erik VERNER
United States
United States
WILLIS, DOUGLAS M
2015-11-0614934885QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR INHIBITORSPrincipia Biopharma, Inc.Patented Case2017-04-259630963US20160130268A1
Kenneth Albert BRAMELD
Erik VERNER
United States
United States
BAKSHI, PANCHAM
2015-05-2014418484TREATMENT OF DRY EYEPRINCIPIA BIOPHARMA INC.Patented Case2017-02-219572811US20150182530A1
Martin Babler
Mary E. Gerritsen
United States
United States
SHTERENGARTS, SAMANTHA L
2015-05-1914443705SUBSTITUTED PYRROLO[2,3-b]PYRAZINES AS JAK3 INHIBITORSPRINCIPIA BIOPHARMA INC.Patented Case2017-06-139676778US20150291600A1
David Michael Goldstein
Kenneth Albert Brameld
Tim Owens
United States
United States
United States
WILLIS, DOUGLAS M
2015-02-2714424480BENZIMIDAZOLE DERIVATIVES AS ITK INHIBITORSPrincipia Biopharma, Inc.Patented Case2017-02-219573958US20150225412A1
Kenneth Albert Brameld
Timothy Owens
United States
United States
STOCKTON, LAURA LYNNE
2014-08-2014464602PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORSPRINCIPIA BIOPHARMA INC.Patented Case2015-01-278940744US20140364410A1
Tim OWENS
Erik VERNER
United States
United States
HENLEY III, RAYMOND J
2014-07-2514374788SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS KINASE INHIBITORSPRINCIPIA BIOPHARMA INC.Patented Case2016-02-239266895US20150094295A1
Tim Owens
Erik Verner
United States
United States
WILLIS, DOUGLAS M
2014-07-2514341421TYROSINE KINASE INHIBITORSPrincipia Biopharma Inc.Patented Case2015-02-248962635US20140336382A1
David Michael GOLDSTEIN
United States
MURRAY, JEFFREY H
2014-04-1714255842TYROSINE KINASE INHIBITORSPrincipia Biopharma Inc.Patented Case2015-07-289090621US20140309223A1
David Michael GOLDSTEIN
United States
MURRAY, JEFFREY H
2014-02-2014185687TYROSINE KINASE INHIBITORSPrincipia Biopharma Inc.Patented Case2015-02-038946241US20140303190A1
David Michael GOLDSTEIN
United States
MURRAY, JEFFREY H
2013-06-2713929179TYROSINE KINASE INHIBITORSPrincipia Biopharma Inc.Patented Case2014-06-248759358
David Michael GOLDSTEIN
United States
MURRAY, JEFFREY H
2013-06-2713929004TYROSINE KINASE INHIBITORSPrincipia Biopharma Inc.Patented Case2014-03-188673925
David Michael Goldstein
MURRAY, JEFFREY H
2013-04-0913859569TYROSINE KINASE INHIBITORSPrincipia Biopharma, Inc.Patented Case2015-02-178957080US20140303161A1
David Michael GOLDSTEIN
Kenneth Albert BRAMELD
United States
United States
MURRAY, JEFFREY H